PlainRecalls

Llorens Pharmaceutical Corp.

Compiled from official public sources by the publisher.

1 recalls on record · Latest: Nov 22, 2017

Subscribe to new Llorens Pharmaceutical Corp. recalls (RSS)

Agency notice ledger

Federal filing book Llorens Pharmaceutical Corp. SINGLE · SINGLE-AGENCY

#10,335 of 14,151 · 1 notices · 0.001% archive

  • BOOK 1 notices
  • RANK #10,335 of 14,151
  • SHARE 0.001% archive
  • AGENCY FDA Drug (1)
  • CAT drugs
  • CATS 1 category
  • LATEST Nov 22, 2017
  • PHOTO —

Llorens Pharmaceutical Corp. accounts for about 0.001% of the 104,423-notice archive on 1 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category →

Where Llorens Pharmaceutical Corp. sits among 14,151 recalling firms

Llorens Pharmaceutical Corp. ranks 10,335th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Llorens Pharmaceutical Corp. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

1 10335th of 14151 the lowest of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

FDA Drug Moderate Nov 22, 2017

Urin D/S Tablets Methenamine 81.6 mg, Sodium Biphosphate 40.8 mg, Phenyl Salicylate 36.2 mg, Methylene Blue 10.8 mg, Hyoscyamine Sulfate 0.12 mg, Rx Only, 100-count bottle, Manufactured For: Llorens Pharmaceutical Corp., International Division, Miami, FL 33166. NDC: 54859-701-10

Frequently Asked Questions

How many federal recall notices name Llorens Pharmaceutical Corp.? ▼
PlainRecalls indexes 1 distinct federal recall events naming Llorens Pharmaceutical Corp., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Llorens Pharmaceutical Corp. sit among other recalling firms? ▼
Llorens Pharmaceutical Corp. ranks #10,335 of 14,151 by distinct recall-event count among 14,151 firms in this archive (tied at the bottom of the notice-count distribution (no firm has fewer notices)). Rank tracks filing frequency, not product danger.
Which agency issues most of Llorens Pharmaceutical Corp.'s notices? ▼
FDA Drug accounts for 1 of this firm's 1 indexed notices.
What product category dominates Llorens Pharmaceutical Corp.'s filing book? ▼
Filings for Llorens Pharmaceutical Corp. span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Llorens Pharmaceutical Corp.: 1 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Llorens Pharmaceutical Corp.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026